| Date | Title | File |
|---|---|---|
|
Oct 31, 2023
|
Q3 2023 Financial and Corporate Update Presentation
|
|
|
Aug 01, 2023
|
Q2 2023 Financial and Corporate Update Presentation
|
|
|
May 02, 2023
|
Q1 2023 Financial and Corporate Update Presentation
|
|
|
Mar 18, 2023
|
AAD 2023: Corporate Presentation Highlighting Dermatology Data in Vitiligo
|
|
|
Feb 06, 2023
|
Q4 2022 Financial and Corporate Update Presentation
|
|
|
Jan 09, 2023
|
JP Morgan Healthcare Conference Presentation
|
|
|
Dec 12, 2022
|
ASH 2022: Corporate Presentation on LIMBER Program
|
|
|
Nov 01, 2022
|
Q3 2022 Financial and Corporate Update Presentation
|
|
|
Aug 02, 2022
|
Q2 2022 Financial and Corporate Update Presentation
|
|
|
Jul 19, 2022
|
Opzelura™ in Vitiligo FDA Approval Presentation
|
PDF 4.8 MB
|
